InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Jenne Kyle. Officer active across 1 company, notably Ionis Pharmaceuticals INC. In total, 5 filings have been published. Split: 0 buy · 1 sell. Total volume traded: €313k. Activity tracked since 15 April 2025. The latest transaction was filed on 15 April 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Jenne Kyle is EVP, Chf GL Pdt Str Ofcr at Ionis Pharmaceuticals INC, listed on XNAS. The record shows 5 filings in total. Across the 5 recent filings available, sales total EUR 312736, the period runs from 2025-04-17 to 2026-04-17, and the most common transaction nature is option exercise.